Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Pridopidine hydrochloride by Prilenia Therapeutics Development for Huntington Disease: Likelihood of Approval
Pridopidine hydrochloride is under clinical development by Prilenia Therapeutics Development and currently in Phase III for Huntington Disease. According to...
Data Insights
Pridopidine hydrochloride by Prilenia Therapeutics Development for Amyotrophic Lateral Sclerosis: Likelihood of Approval
Pridopidine hydrochloride is under clinical development by Prilenia Therapeutics Development and currently in Phase III for Amyotrophic Lateral Sclerosis. According...